BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19806186)

  • 21. Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes.
    Franquelim HG; Chiantia S; Veiga AS; Santos NC; Schwille P; Castanho MA
    AIDS; 2011 Feb; 25(4):419-28. PubMed ID: 21245727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced antibody responses to an HIV-1 membrane-proximal external region antigen in mice reconstituted with cultured lymphocytes.
    Holl TM; Yang G; Kuraoka M; Verkoczy L; Alam SM; Moody MA; Haynes BF; Kelsoe G
    J Immunol; 2014 Apr; 192(7):3269-79. PubMed ID: 24591365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
    Virology; 2017 May; 505():113-126. PubMed ID: 28237764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.
    Zhang MY; Vu BK; Choudhary A; Lu H; Humbert M; Ong H; Alam M; Ruprecht RM; Quinnan G; Jiang S; Montefiori DC; Mascola JR; Broder CC; Haynes BF; Dimitrov DS
    J Virol; 2008 Jul; 82(14):6869-79. PubMed ID: 18480433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
    Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
    J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry.
    Kim M; Song L; Moon J; Sun ZY; Bershteyn A; Hanson M; Cain D; Goka S; Kelsoe G; Wagner G; Irvine D; Reinherz EL
    J Biol Chem; 2013 Nov; 288(44):31888-901. PubMed ID: 24047898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
    Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
    Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
    Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1.
    Boehme KW; Ikizler M; Iskarpatyoti JA; Wetzel JD; Willis J; Crowe JE; LaBranche CC; Montefiori DC; Wilson GJ; Dermody TS
    mSphere; 2016; 1(3):. PubMed ID: 27303748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and analysis of the membrane proximal external region epitopes of HIV-1.
    Ingale S; Gach JS; Zwick MB; Dawson PE
    J Pept Sci; 2010 Dec; 16(12):716-22. PubMed ID: 21104968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation.
    Liu J; Deng Y; Dey AK; Moore JP; Lu M
    Biochemistry; 2009 Apr; 48(13):2915-23. PubMed ID: 19226163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
    Vassell R; He Y; Vennakalanti P; Dey AK; Zhuang M; Wang W; Sun Y; Biron-Sorek Z; Srivastava IK; LaBranche CC; Montefiori DC; Barnett SW; Weiss CD
    PLoS One; 2015; 10(6):e0128562. PubMed ID: 26087072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications.
    Bryson S; Julien JP; Hynes RC; Pai EF
    J Virol; 2009 Nov; 83(22):11862-75. PubMed ID: 19740978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
    Matyas GR; Wieczorek L; Beck Z; Ochsenbauer-Jambor C; Kappes JC; Michael NL; Polonis VR; Alving CR
    AIDS; 2009 Oct; 23(16):2069-77. PubMed ID: 19710597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.
    Alam SM; Scearce RM; Parks RJ; Plonk K; Plonk SG; Sutherland LL; Gorny MK; Zolla-Pazner S; Vanleeuwen S; Moody MA; Xia SM; Montefiori DC; Tomaras GD; Weinhold KJ; Karim SA; Hicks CB; Liao HX; Robinson J; Shaw GM; Haynes BF
    J Virol; 2008 Jan; 82(1):115-25. PubMed ID: 17942537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01.
    Pinto D; Fenwick C; Caillat C; Silacci C; Guseva S; Dehez F; Chipot C; Barbieri S; Minola A; Jarrossay D; Tomaras GD; Shen X; Riva A; Tarkowski M; Schwartz O; Bruel T; Dufloo J; Seaman MS; Montefiori DC; Lanzavecchia A; Corti D; Pantaleo G; Weissenhorn W
    Cell Host Microbe; 2019 Nov; 26(5):623-637.e8. PubMed ID: 31653484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides.
    Mohan T; Verma P; Rao DN
    Immunobiology; 2014 Apr; 219(4):292-301. PubMed ID: 24290973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.
    Alam SM; McAdams M; Boren D; Rak M; Scearce RM; Gao F; Camacho ZT; Gewirth D; Kelsoe G; Chen P; Haynes BF
    J Immunol; 2007 Apr; 178(7):4424-35. PubMed ID: 17372000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.